Prime Medicine, Inc. (PRME)
Largest Insider Buys in Sector
PRME Stock Price History Chart
PRME Stock Performance
About Prime Medicine, Inc.
Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address diseases by deploying gene editing technology. It offers Prime Editors with a Prime Editor protein, comprising a fusion between a Cas protein and a reverse transcriptase enzyme; and a pegRNA, which targets the Prime Editor to a specific genomic location and provides a template for making the desired edit to the target DNA sequence. The company was incorporated in 2019 and is headquartered in Cambridge, Massachusetts.
Insider Activity of Prime Medicine, Inc.
Over the last 12 months, insiders at Prime Medicine, Inc. have bought $60M and sold $0 worth of Prime Medicine, Inc. stock.
On average, over the past 5 years, insiders at Prime Medicine, Inc. have bought $47M and sold $20.01M worth of stock each year.
Highest buying activity among insiders over the last 12 months: NELSEN ROBERT () — $140M. ARCH Venture Partners X, LLC (10 percent owner) — $40M. ARCH Venture Partners XII, LLC (10 percent owner) — $40M.
The last purchase of 3,200,000 shares for transaction amount of $20M was made by NELSEN ROBERT () on 2024‑02‑15.
List of Insider Buy and Sell Transactions, Prime Medicine, Inc.
| 2024-02-15 | 3.2M 4.6348% | $6.25 | $20M | -36.86% | ||||
| 2024-02-15 | 10 percent owner | 3.2M 4.6348% | $6.25 | $20M | -36.86% | |||
| 2024-02-15 | 10 percent owner | 3.2M 4.6348% | $6.25 | $20M | -36.86% | |||
| 2023-06-21 | Sale | 10 percent owner | 19,003 0.0659% | $14.97 | $284,496 | -48.21% | ||
| 2023-06-20 | Sale | 10 percent owner | 37,405 0.1305% | $15.06 | $563,248 | -48.52% | ||
| 2023-06-16 | Sale | 10 percent owner | 6,532 0.0227% | $15.02 | $98,109 | -46.91% | ||
| 2023-06-15 | Sale | 10 percent owner | 66,659 0.2304% | $14.92 | $994,326 | -47.17% | ||
| 2023-06-14 | Sale | 10 percent owner | 28,960 0.0998% | $14.87 | $430,684 | -46.33% | ||
| 2023-06-13 | Sale | 10 percent owner | 28,100 0.0985% | $15.13 | $425,102 | -45.81% | ||
| 2023-06-12 | Sale | 10 percent owner | 16,031 0.0557% | $14.98 | $240,151 | -45.41% | ||
| 2023-06-09 | Sale | 10 percent owner | 15,672 0.0526% | $14.48 | $226,984 | -44.48% | ||
| 2023-06-08 | Sale | 10 percent owner | 5,000 0.0182% | $15.74 | $78,687 | -46.30% | ||
| 2023-06-07 | Sale | 10 percent owner | 15,000 0.0588% | $16.92 | $253,871 | -51.97% | ||
| 2023-06-06 | Sale | 10 percent owner | 29,975 0.1182% | $17.02 | $510,166 | -52.67% | ||
| 2023-06-05 | Sale | 10 percent owner | 22,434 0.0868% | $16.70 | $374,612 | -51.73% | ||
| 2023-06-01 | Sale | 10 percent owner | 45,223 0.1504% | $14.36 | $649,194 | -44.78% | ||
| 2023-05-31 | Sale | 10 percent owner | 16,633 0.0526% | $13.65 | $227,004 | -40.60% | ||
| 2023-05-30 | Sale | 10 percent owner | 16,805 0.0534% | $13.70 | $230,240 | -40.49% | ||
| 2023-05-26 | Sale | 10 percent owner | 12,602 0.04% | $13.70 | $172,603 | -38.88% | ||
| 2023-05-25 | Sale | 10 percent owner | 23,161 0.0718% | $13.38 | $309,973 | -37.94% |
Insider Historical Profitability
| NELSEN ROBERT | 3200000 2.4398% | $2.90 | 2 | 0 | <0.0001% | |
| ARCH Venture Partners X, LLC | 10 percent owner | 3200000 2.4398% | $2.90 | 2 | 0 | <0.0001% |
| ARCH Venture Partners XII, LLC | 10 percent owner | 3200000 2.4398% | $2.90 | 1 | 0 | |
| Cahill Thomas | director | 5305679 4.0452% | $2.90 | 1 | 0 | <0.0001% |
| GV 2019 GP, L.L.C. | 10 percent owner | 0 0% | $2.90 | 1 | 30 | <0.0001% |